Aberrant expression of Runx2 has been linked with the progression of breast cancer and development of bone metastasis through the transcriptional upregulation of genes including VEGF, MMP-2, 9, 13, and IL-6 among others, which serve to promote tumor cell migration and invasion. The gene discussed is RUNX2; the disease is breast carcinoma.